G. Smith

3.0k citations

94 papers · 2.0k indexed · h-index 27

Pharmacology top 1%
- Alkaloids: synthesis and pharmacology 17
- Pharmacogenetics and Drug Metabolism 7
Organic Chemistry top 2%
- Chemical synthesis and alkaloids 12
- Axial and Atropisomeric Chirality Synthesis 6
- Synthesis and Reactions of Organic Compounds 6
Biochemistry top 5%
- Traditional and Medicinal Uses of Annonaceae 7
Pharmaceutical Science top 5%
- Fluorine in Organic Chemistry 6
Molecular Biology top 10%
Computational Theory and Mathematics
- Computational Drug Discovery Methods 10

Co-authors: Noreen F. Rizvi G.N. Smith Arnold H. Ratcliffe J. A. Joule David Bruce Colin H. L. Kennard Zhi‐Jie Ni Leo A. Paquette
Cited by: Pharmacology Organic Chemistry Biochemistry
Journals: Bioorganic & Medicinal Chemistry Letters (4 papers)Regulatory Toxicology and Pharmacology (4 papers)Tetrahedron Letters (4 papers)
Partner nations: United States United Kingdom Australia

In The Last Decade

G. Smith

91 papers receiving 1.9k citations

Peers

Countries citing papers authored by G. Smith

Since Specialization

Citations

This map shows the geographic impact of G. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Smith more than expected).

Fields of papers citing papers by G. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Smith. The network helps show where G. Smith may publish in the future.

Co-authorship network

The 25 scholars most cited alongside G. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G. Smith Line = papers co-authored together G. Smith links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	N-Nitrosamine drug substance related impurities (NDSRIs) – A proposal for the addition of subcategories to carcinogenic potency categorization approach categories 1 and 2 for NDSRIs with a molecular weight > 200 Da Regulatory Toxicology and Pharmacology ·Joel P. Bercu,Olivier Dirat,Krista L. Dobo,Robert A. Jolly,Michelle Kenyon,James Harvey,Raphael Nudelman,G. Smith,Alejandra Trejo‐Martin,P Kirshmeier	2024	7
2	Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic Potency Chemical Research in Toxicology ·David J. Snodin,Alejandra Trejo‐Martin,David J. Ponting,G. Smith,Andreas Czich,Kevin P. Cross,Laura Custer,Iciar Cimas Hernando,Nigel Greene,Amit S. Kalgutkar,S. A. Stalford,Rachael E. Tennant,Esther Vock,Adam Zalewski,Zhang Long-zh,Krista L. Dobo	2024	28
3	Control of N-nitrosamine impurities in drug products: Progressing the current CPCA framework and supporting the derivation of robust compound specific acceptable intakes Regulatory Toxicology and Pharmacology ·David J. Ponting,Andreas Czich,Susan P. Felter,Susanne Glowienke,James Harvey,Raphael Nudelman,Joerg Schlingemann,Stéphanie Simon,G. Smith,Andrew Teasdale,Robert Thomas	2024	7
4	The Nitrosamine “Saga”: Lessons Learned from Five Years of Scrutiny Organic Process Research & Development ·Raphael Nudelman,Mahmoud Kahlifa,Bernard Noveloso,David J. Ponting,Joerg Schlingemann,Stéphanie Simon,G. Smith,Andrew Teasdale,R. C. Maskall	2023	49
5	Revisiting the Landscape of Potential Small and Drug Substance Related Nitrosamines in Pharmaceuticals Journal of Pharmaceutical Sciences ·Michael J. Burns,David J. Ponting,Robert S. Foster,Benjamin P. Thornton,Q. M. Zhang,G. Smith,Ian W. Ashworth,Andrew Teasdale,Stéphanie Simon,Joerg Schlingemann	2023	20
6	Prediction of In Vivo Pharmacokinetic Parameters and Time–Exposure Curves in Rats Using Machine Learning from the Chemical Structure Molecular Pharmaceutics ·Olga Obrezanova,Reda Hosny Ibrahim,Thomas M. Whitehead,G. Lataillade,Andreas Bender,Filip Miljković,Piotr Grabowski,AngelaDi Cosola,G.I. Skryabina,G. J. Conduit,Matthew Segall,G. Smith,Beth Williamson,Susanne Winiwarter,Nigel Greene	2022	46
7	Deriving waveform parameters from calcium transients in human iPSC-derived cardiomyocytes to predict cardiac activity with machine learning Stem Cell Reports ·Hongbin Yang,Katie Carruel,Barsha Lamichhane,Amy Pointon,Olga Obrezanova,Kylie A. Beattie,Peter Clements,James Harvey,G. Smith,Andreas Bender	2022	12
8	Development of a Platform To Enable Efficient Permeability Evaluation of Novel Organo-Peptide Macrocycles ACS Medicinal Chemistry Letters ·Brett A. Hopkins,Hyelee Lee,Sookhee Ha,Lisa Nogle,Bérengère Sauvagnat,Sonia Septa Arini,G. Smith,Nunzio Sciammetta	2019	9
9	Targeting RNA with Small Molecules: Identification of Selective, RNA-Binding Small Molecules Occupying Drug-Like Chemical Space SLAS DISCOVERY ·Noreen F. Rizvi,John P. Santa Maria,Ali Nahvi,Joel A. Klappenbach,Daniel J. Klein,Patrick J. Curran,Matthew Richards,D. Jüngst,P Saradjian,Julja Burchard,Rodrigo Aguilar,Jeannie T. Lee,Peter J. Dandliker,G. Smith,Peter S. Kutchukian,Elliott Nickbarg	2019	69
10	Discovery of Selective RNA-Binding Small Molecules by Affinity-Selection Mass Spectrometry ACS Chemical Biology ·Noreen F. Rizvi,John A. Howe,Ali Nahvi,Daniel J. Klein,Thierry Fischmann,Hai‐Young Kim,Mark A. McCoy,Scott S. Walker,Alan Hruza,Matthew Richards,D. Jüngst,P Saradjian,Margaret T. Butko,Zaiakin Es,Julja Burchard,Corey Strickland,Peter J. Dandliker,G. Smith,Elliott Nickbarg	2018	81
11	Discovery of 5-Amino- N -(1 H -pyrazol-4-yl)pyrazolo[1,5- a ]pyrimidine-3-carboxamide Inhibitors of IRAK4 ACS Medicinal Chemistry Letters ·Jongwon Lim,Michael D. Altman,James Α. Baker,Jason D. Brubaker,Hongmin Chen,Yiping Chen,Thierry Fischmann,G Mitra,Melanie A. Kleinschek,Genealogist,Charles A. Lesburg,John Maclean,Lily Y. Moy,Victoria del Carmen Bravo Ahuja Roth,Jeremy Presland,Larissa Rakhilina,G. Smith,Dietrich Steinhuebel,Ruojing Yang	2015	31
12	Connecting Landlocked Developing Countries to Markets: Trade Corridors in the 21st Century RePEc: Research Papers in Economics ·Hong Jig Kim,J.G.M. Thunnissen,G. Smith,Franco Nogueira	2011	11
13	Designing Drugs to Avoid Toxicity Progress in medicinal chemistry ·G. Smith	2011	89
14	Medicinal Chemistry by the Numbers: The Physicochemistry, Thermodynamics and Kinetics of Modern Drug Design Progress in medicinal chemistry ·G. Smith	2009	35
15	Structure–activity relationships of novel non-competitive mGluR1 antagonists: A potential treatment for chronic pain Bioorganic & Medicinal Chemistry Letters ·Dafydd R. Owen,Brigitte Probst,Payton Me,Alexis Prasov,Gareth W. Harbottle,Simon J. Mantell,Graham N. Maw,Simon A. Osborne,H. Rees,Rajan Arianayagam,Miguel Ángel Rosique Valverde,G. Smith	2006	15
16	Unambiguous structural assignment of monoanils obtained from 2,3-pyridinediamines Queensland's institutional digital repository (The University of Queensland) ·P. K. Dubey,Ramesh Kumar,Päivi Kivelä,Jose Antonio Scaramucci,G. Smith,Collin H. L. Kennard	2004	3
17	Structural studies of polychlorinated hydrocarbons. V. 1,1,1,2-Tetrachloro-2,2-bis(p-chlorophenyl)ethane and 1,1,1-tribromo-2,2-bis(pchlorophenyl)ethane Acta Crystallographica Section B ·Sven Hovmöller,G. Smith,Colin H. L. Kennard	1978	6
18	The sulphonation of indole and some of its simple alkyl derivatives Tetrahedron ·G. Smith,尚武髙瀬	1973	10
19	The Acid-Catalyzed Polymerization of Pyrroles and Indoles PubMed ·G. Smith	1963	70
20	884. Indoles. Part IV. The reaction between 1,3-dimethylindole and mesityl oxide Journal of the Chemical Society (Resumed) ·Brian Robinson,G. Smith	1960	7

About G. Smith

G. Smith is a scholar working on Pharmacology, Organic Chemistry and Biochemistry, having authored 94 papers that have together received 2.0k indexed citations. Recurring topics across this work include Alkaloids: synthesis and pharmacology (17 papers), Chemical synthesis and alkaloids (12 papers), Computational Drug Discovery Methods (10 papers), Pharmacogenetics and Drug Metabolism (7 papers), Traditional and Medicinal Uses of Annonaceae (7 papers), Fluorine in Organic Chemistry (6 papers), Axial and Atropisomeric Chirality Synthesis (6 papers) and Synthesis and Reactions of Organic Compounds (6 papers). The work is most often cited by research in Pharmacology (279 citations), Organic Chemistry (800 citations) and Biochemistry (122 citations). G. Smith has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Noreen F. Rizvi, G.N. Smith, Arnold H. Ratcliffe, J. A. Joule, David Bruce, Colin H. L. Kennard, Zhi‐Jie Ni, Leo A. Paquette, David J. Ponting and Elliott Nickbarg. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Regulatory Toxicology and Pharmacology, Tetrahedron Letters, Tetrahedron and Australian Journal of Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact